Taconic Biosciences and Cellaria Biosciences Agree to Scientific Collaboration to Facilitate Xenograft Use in Oncology Research
Taconic Biosciences and Cellaria Biosciences announced that the two companies have entered into a scientific collaboration designed to facilitate and improve the utility of patient-derived xenografts (PDXs) in animal models for oncology and immuno-oncology research. Cellaria's novel methodologies for generating cells from patient tumors will complement Taconic's industry-leading portfolio of tissue humanized mouse models, which are well-suited as hosts for PDXs.
View full press release